Professional Summary
Education & Certifications
- Residency: University of South Florida Internal Medicine Residency Program FL
- Fellowship: University of South Florida Infectious Diseases Fellowship FL
- Board Certification: American Board of Internal Medicine, Infectious Disease (2019)
-
- Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
- Medical Education: Edward Via College of Osteopathic Medicine (2014) VA
Administrative Appointments
- Associate Medical Director of Infection Prevention & Control, Stanford Health Care (2023 - Present)
-
Publications
-
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien, M. P., Forleo-Neto, E., Musser, B. J., Isa, F., Chan, K.-C. C., Sarkar, N., … Weinreich, D. M. (2021). Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. The New England Journal of Medicine, 385(13), 1184–1195. -
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., … Yancopoulos, G. D. (2021). REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. The New England Journal of Medicine, 385(23), e81. -
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien, M. P., Forleo-Neto, E., Sarkar, N., Isa, F., Hou, P., Chan, K.-C. C., … Weinreich, D. M. (2022). Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. -
-
Syphilis Treatment: Systematic Review and Meta-Analysis Investigating Nonpenicillin Therapeutic Strategies.
Callado, G. Y., Gutfreund, M. C., Pardo, I., Hsieh, M. K., Lin, V., Sampson, M. M., … Marra, A. R. (2024). Syphilis Treatment: Systematic Review and Meta-Analysis Investigating Nonpenicillin Therapeutic Strategies. Open Forum Infectious Diseases, 11(4), ofae142. -
Beyond the surface: a color-inclusive guide to central line site assessment.
Herrera, M., Eichenblat, S., Campbell, E., Shick, J., Brown, H., Brinkley, C., … Sampson, M. M. (2024). Beyond the surface: a color-inclusive guide to central line site assessment. Antimicrobial Stewardship & Healthcare Epidemiology : ASHE, 4(1), e41. -
Racial disparities in central line-associated bloodstream infections: the impact of the COVID-19 pandemic.
DeWitt, M. E., Sampson, M. M., Kester, S., MacNeill, E., & Passaretti, C. (2024). Racial disparities in central line-associated bloodstream infections: the impact of the COVID-19 pandemic. Infection Control and Hospital Epidemiology, 1–5. -
Skin and Soft Tissue Infections in Patients with Diabetes Mellitus.
Polk, C., Sampson, M. M., Roshdy, D., & Davidson, L. E. (2021). Skin and Soft Tissue Infections in Patients with Diabetes Mellitus. Infectious Disease Clinics of North America, 35(1), 183–197. -
Reply.
Ramprasad, C., Mgbako, O., Sampson, M., Passaretti, C., & Moshiree, B. (2023). Reply. Diseases of the Colon and Rectum, 66(6), e311. -
Mpox (Monkeypox) Infection During Pregnancy.
Sampson, M. M., Magee, G., Schrader, E. A., Dantuluri, K. L., Bukhari, A., Passaretti, C., … Weinrib, D. (2023). Mpox (Monkeypox) Infection During Pregnancy. Obstetrics and Gynecology, 141(5), 1007–1010. -
Reflecting on Resident Attitudes About Quality Improvement.
Sampson, M. M., Cheng, S., & Olson, D. A. (2017). Reflecting on Resident Attitudes About Quality Improvement. Academic Medicine : Journal of the Association of American Medical Colleges, 92(11), 1509. -
Perianal and Rectal Lesions in the Monkeypox Outbreak: Diagnosis and Proposed Management.
Ramprasad, C., Mgbako, O., Sampson, M., Passaretti, C., & Moshiree, B. (2022). Perianal and Rectal Lesions in the Monkeypox Outbreak: Diagnosis and Proposed Management. Diseases of the Colon and Rectum, 65(12), 1422–1424. -
Cholecystitis as a Possible Immunologic Consequence of COVID-19; Case Series from a Large Healthcare System.
Polk, C., Sampson, M. M., Jacobs, A., Kooken, B., Ludden, T., Passaretti, C. L., & Leonard, M. (2022). Cholecystitis as a Possible Immunologic Consequence of COVID-19; Case Series from a Large Healthcare System. The American Journal of the Medical Sciences, 363(5), 456–458. -
Monkeypox testing delays: The need for drastic expansion of education and testing for monkeypox virus.
Sampson, M. M., Polk, C. M., Fairman, R. T., DeWitt, M. E., Leonard, M. K., Davidson, L., … Passaretti, C. L. (2023). Monkeypox testing delays: The need for drastic expansion of education and testing for monkeypox virus. Infection Control and Hospital Epidemiology, 44(2), 348–349. -
Global monkeypox case hospitalisation rates: A rapid systematic review and meta-analysis.
DeWitt, M. E., Polk, C., Williamson, J., Shetty, A. K., Passaretti, C. L., McNeil, C. J., … Sanders, J. W. (2022). Global monkeypox case hospitalisation rates: A rapid systematic review and meta-analysis. EClinicalMedicine, 54, 101710. -
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Temesgen, Z., Burger, C. D., Baker, J., Polk, C., Libertin, C. R., Kelley, C. F., … Badley, A. D. (2022). Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. The Lancet. Respiratory Medicine, 10(3), 237–246. -
Evaluation of a health system's implementation of a monkeypox care model under the RE-AIM framework.
Polk, C., Sampson, M., Fairman, R. T., DeWitt, M. E., Leonard, M., Neelakanta, A., … Passaretti, C. (2023). Evaluation of a health system's implementation of a monkeypox care model under the RE-AIM framework. Therapeutic Advances in Infectious Disease, 10, 20499361231158463. -
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants.
Reeves, K. D., Polk, C. M., Cox, L. A., Fairman, R. T., Hawkins, G. A., Passaretti, C. L., & Sampson, M. M. (2022). Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants. Antimicrobial Stewardship & Healthcare Epidemiology : ASHE, 2(1), e143. -
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Temesgen, Z., Kelley, C. F., Cerasoli, F., Kilcoyne, A., Chappell, D., Durrant, C., … Marconi, V. C. (2023). C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial. Thorax, 78(6), 606–616. -
A Plethora of Pustules: Acute Generalized Exanthematous Pustulosis.
Sampson, M. M., Klinkova, O., Vitko, J., & Casanas, B. (2018). A Plethora of Pustules: Acute Generalized Exanthematous Pustulosis. The American Journal of Medicine, 131(6), 639–641. -
A case of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reinfection within ninety days of primary infection in a healthcare worker.
Sampson, M. M., Reeves, K. D., Polk, C. M., Hawkins, G. A., & Passaretti, C. L. (2022). A case of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reinfection within ninety days of primary infection in a healthcare worker. Infection Control and Hospital Epidemiology, 43(12), 2002–2003. -
Mucositis and oral infections secondary to gram negative rods in patients with prolonged neutropenia.
Sampson, M. M., Nanjappa, S., & Greene, J. N. (2017). Mucositis and oral infections secondary to gram negative rods in patients with prolonged neutropenia. IDCases, 9, 101–103. -
Prevalence of gastrointestinal parasites in children from Verón, a rural city of the Dominican Republic.
Childers, K. A., Palmieri, J. R., Sampson, M., & Brunet, D. (2014). Prevalence of gastrointestinal parasites in children from Verón, a rural city of the Dominican Republic. Research and Reports in Tropical Medicine, 5, 45–53. -
Clinical decision support in the electronic health record: a primer for antimicrobial stewards and infection preventionists: work smarter so end users don't work harder.
Smith, M. R., Lee, J. J., Holubar, M., Salinas, J. L., Sampson, M. M., Medford, R. J., & Chang, A. (2024). Clinical decision support in the electronic health record: a primer for antimicrobial stewards and infection preventionists: work smarter so end users don't work harder. Antimicrobial Stewardship & Healthcare Epidemiology : ASHE, 4(1), e204. -
Respiratory equality: let's stop playing favorites with COVID-19 in the healthcare setting.
Passaretti, C. L., Bischoff, W., Chan, J., Diekema, D. J., Doron, S., Estelle, C., … Marschall, J. (2024). Respiratory equality: let's stop playing favorites with COVID-19 in the healthcare setting. Infection Control and Hospital Epidemiology, 1–2. -
Effective mitigation of blood culture bottle shortage with diagnostic stewardship interventions.
Hudson, J., Rodriguez Nava, G., Sampson, M. M., Chang, A., Dussaq, A. M., Salinas, J. L., … Banaei, N. (2025). Effective mitigation of blood culture bottle shortage with diagnostic stewardship interventions. Journal of Clinical Microbiology, e0170124. -
Beyond the hospital doors: challenges and insights from a multi-state healthcare system outpatient infection prevention program.
Heisner, K., Layell, J., Citronberg, R., Sampson, M., Passaretti, C., & Skelton, L. (2025). Beyond the hospital doors: challenges and insights from a multi-state healthcare system outpatient infection prevention program. Infection Control and Hospital Epidemiology, 1–3.
-
Syphilis Treatment: Systematic Review and Meta-Analysis Investigating Nonpenicillin Therapeutic Strategies.
Practice Locations
SHC- Infectious Disease Palo Alto, CA
Palo Alto, CAImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records